• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性肾结石患者尿液的长期酸化

Long-term acidification of urine in patients treated for infected renal stones.

作者信息

Wall I, Tiselius H G

机构信息

Department of Urology, University Hospital, Linköping, Sweden.

出版信息

Urol Int. 1990;45(6):336-41. doi: 10.1159/000281732.

DOI:10.1159/000281732
PMID:2288050
Abstract

The effects of ammonium chloride, methenamine hippurate and ascorbic acid on urinary pH was studied in 14 normal subjects. A statistically significant reduction of urinary pH was recorded with ammonium chloride in daily doses of 1.5 and 3 g, but not with 2 g of methenamine hippurate or 1.8 g of ascorbic acid. Long-term treatment with ammonium chloride in doses between 1.5 and 3 g was given to 11 patients in order to reduce the risk of new stone formation or growth of fragments remaining after disintegration of infected renal stones. Biochemical stone analyses showed struvite in 9 of the treated stones, and urine cultures verified the presence of urease-producing bacteria in 10 patients. Apart from ammonium chloride, the patients were treated with antibiotics, in 4 patients continuously and in the others during periods from 2 to 34 months. The patients were followed for an average period of 32 months. No adverse reactions were recorded with the dosage used. Initially, 6 patients were stone-free, whereas 5 had residual stone fragments with a largest diameter ranging from 4 to 20 mm. At follow-up, 2 patients were still stone-free, and of 5 patients with residual fragments 1 showed stable disease and 3 an improved stone situation. In 5 patients, 3 of whom had residual stone fragments, antibiotic treatment had been interrupted without infectious relapse.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在14名正常受试者中研究了氯化铵、马尿酸乌洛托品和维生素C对尿液pH值的影响。每日剂量为1.5克和3克的氯化铵可使尿液pH值显著降低,但2克马尿酸乌洛托品或1.8克维生素C则不会。为降低感染性肾结石分解后新结石形成或残留碎片生长的风险,对11名患者进行了剂量在1.5至3克之间的氯化铵长期治疗。结石生化分析显示,9颗治疗后的结石为鸟粪石,尿液培养证实10名患者存在产脲酶细菌。除氯化铵外,患者还接受了抗生素治疗,4名患者持续使用,其他患者使用时间为2至34个月。对患者平均随访32个月。所用剂量未记录到不良反应。最初,6名患者无结石,而5名患者有残留结石碎片,最大直径为4至20毫米。随访时,2名患者仍无结石,5名有残留碎片的患者中,1名病情稳定,3名结石情况有所改善。5名患者中,3名有残留结石碎片,抗生素治疗中断后未出现感染复发。(摘要截断于250字)

相似文献

1
Long-term acidification of urine in patients treated for infected renal stones.感染性肾结石患者尿液的长期酸化
Urol Int. 1990;45(6):336-41. doi: 10.1159/000281732.
2
[Urinary calculi and infection].[尿路结石与感染]
Urologia. 2014 Apr-Jun;81(2):93-8. doi: 10.5301/uro.5000073. Epub 2014 May 27.
3
Formaldehyde generation from methenamine salts in spinal cord injury.脊髓损伤中乌洛托品盐产生甲醛的情况。
Arch Phys Med Rehabil. 1984 May;65(5):257-9.
4
Long-term treatment with methenamine hippurate in recurrent urinary tract infection.马尿酸乌洛托品用于复发性尿路感染的长期治疗。
Acta Med Scand. 1975 Jul-Aug;198(1-2):81-5. doi: 10.1111/j.0954-6820.1975.tb19508.x.
5
The effects of methenamine-hippurate upon urinary risk factors for renal stone formation.马尿酸乌洛托品对肾结石形成的尿液危险因素的影响。
Scand J Urol Nephrol. 1985;19(2):125-7. doi: 10.3109/00365598509180239.
6
Infectious nephrolithiasis: results of treatment with methenamine mandelate.
Contrib Nephrol. 1987;58:233-5. doi: 10.1159/000414526.
7
[The preventive effect of methenamine hippurate (Haiprex) on urinary infections after short-term catheterization. A clinical study].[马尿酸乌洛托品(海普瑞克斯)对短期导尿后泌尿系统感染的预防作用。一项临床研究]
Ugeskr Laeger. 1984 May 7;146(19):1433-4.
8
Effect of nitrofurantoin and methenamine hippurate prophylaxis on bacteria and yeasts in the urine of patients with an indwelling catheter.呋喃妥因和马尿酸乌洛托品预防对留置导管患者尿液中细菌和酵母菌的影响。
J Hosp Infect. 1982 Dec;3(4):357-64. doi: 10.1016/0195-6701(82)90068-8.
9
Methenamine hippurate for preventing urinary tract infections.马尿酸乌洛托品用于预防尿路感染。
Cochrane Database Syst Rev. 2002(1):CD003265. doi: 10.1002/14651858.CD003265.
10
Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder.酸化乌洛托品扁桃酸盐:神经源性膀胱患者有效的尿路抗菌剂。
Mayo Clin Proc. 1984 Aug;59(8):523-9. doi: 10.1016/s0025-6196(12)61489-x.

引用本文的文献

1
Modulators of urinary pH in the context of urinary stone disease: a literature review.尿路结石病背景下尿液pH值的调节剂:文献综述
Transl Androl Urol. 2025 Aug 30;14(8):2428-2438. doi: 10.21037/tau-2025-275. Epub 2025 Aug 26.
2
Analysis of components and related risk factors of urinary stones: a retrospective study of 1055 patients in southern China.分析尿路结石的成分及相关危险因素:对中国南方 1055 例患者的回顾性研究。
Sci Rep. 2024 Nov 16;14(1):28357. doi: 10.1038/s41598-024-80147-1.
3
International Alliance of Urolithiasis (IAU) guideline on staghorn calculi management.
国际尿石症联盟(IAU)鹿角结石管理指南。
World J Urol. 2024 Mar 25;42(1):189. doi: 10.1007/s00345-024-04816-6.
4
The Saudi urological association guidelines on urolithiasis.沙特泌尿外科协会尿路结石指南。
Urol Ann. 2024 Jan-Mar;16(1):1-27. doi: 10.4103/ua.ua_120_23. Epub 2024 Jan 25.
5
Vitamin C inhibits crystallization of struvite from artificial urine in the presence of Pseudomonas aeruginosa.维生素 C 可抑制铜绿假单胞菌存在时人工尿液中鸟粪石的结晶。
Int Braz J Urol. 2018 Nov-Dec;44(6):1234-1242. doi: 10.1590/S1677-5538.IBJU.2017.0656.
6
[Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].[脊髓脊膜膨出患者的神经源性膀胱功能障碍:S2k诊断与治疗指南]
Urologe A. 2015 Feb;54(2):239-53. doi: 10.1007/s00120-013-3403-2.
7
Methenamine hippurate for preventing urinary tract infections.马尿酸乌洛托品用于预防尿路感染。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD003265. doi: 10.1002/14651858.CD003265.pub3.
8
Antibiotics therapy was effective in preventing bilateral staghorn renal matrix stones.
Urol Res. 2011 Feb;39(1):69-72. doi: 10.1007/s00240-010-0252-y. Epub 2010 Jan 28.
9
[Urological problems in patients with meningomyelocele. Diagnostic studies and management].[脊髓脊膜膨出患者的泌尿系统问题。诊断研究与管理]
Urologe A. 2007 Dec;46(12):1620-42. doi: 10.1007/s00120-007-1522-3.
10
In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria.对一种针对由硝酸盐还原菌引起的尿路感染的新疗法的体外评估。
Antimicrob Agents Chemother. 2003 Dec;47(12):3713-8. doi: 10.1128/AAC.47.12.3713-3718.2003.